Skip to main content

Table 1 Characteristics of HSPC apheresis products subjected to cryopreservation

From: Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site

 

n

Median

Range (IQR)

Apheresis products

100

  

Collection centers

30

  

Apheresis products per collection center

 

2

1–19 (1–4.25)

Transplant centers

19

  

Products per transplant center

 

3

1–27 (1–6)

Time between apheresis end and cryopreservation (h)

88

22

2.5–54 (21–24.00)

Time between DMSO addition and cryopreservation (min)

100

27

13–45 (21–33)

Product volume before cryopreservation (mL) – CPC

100

301

81–565 (222–351)

Product volume after apheresis (mL) – collection center

79

284

86–555 (224–358)